AppleNASDAQ:AAPL
Apple Stock (AAPL) Gets Rare Barclays Sell as Soft iPhone Demand, AI Doubts Split Wall Street
Barclays stuck to its bearish stance on Apple this day, bucking the rally in U.S. tech. Analyst Tim Long kept his Sell rating and…
Market intelligence
Khadija Saeed
All coverage
Khadija Saeed
NASDAQ:ZStock Market
Mortgage Rates Today: 30-Year Fixed Hovers Near Six-Month High as Spring Buyers Face Fresh Pressure
Mortgage rates in the U.S. held stubbornly high on Tuesday, delivering another setback for buyers as the spring home-shopping rush heats up. For a…
Energy MarketsNASDAQ:CME
Natural Gas Price Today: European Gas Slips on Profit-Taking as EU Weighs New Crisis Measures
European natural gas prices dropped early Tuesday, with the Dutch front-month TTF contract—Europe’s flagship wholesale gas price—off 2.5% at 53.55 euros per megawatt hour…
Energy MarketsOil Prices
Oil Prices Today: Brent Whipsaws as Iran Peace Hopes Hit OPEC Supply Shock
Oil prices whipsawed Tuesday after unverified chatter about Iran signaling willingness to end the conflict sent the June Brent contract tumbling over $3. The…
CryptocurrencyLSE:STAN
XRP Price Today: Why Fresh Inflows Still Can’t Stop the Slide Toward $1.30
XRP was last seen holding around $1.31 on Tuesday, slipping roughly 2% over the past day and testing $1.30 after logging its third consecutive…
CryptocurrencyNASDAQ:MSTR
Bitcoin Price Today: BTC Briefly Tops $68,000 as Iran Off-Ramp Talk Lifts Risk Mood
Bitcoin edged higher on Tuesday, briefly climbing past $68,000 after news surfaced that U.S. President Donald Trump might consider ending military operations against Iran,…
Precious MetalsSilver Prices
Silver Price Today: Spot Silver Jumps 6.7% as Dollar Softens, but March Losses Still Bite
Spot silver jumped 6.7% to $74.64 an ounce on Tuesday, bouncing alongside other precious metals as the dollar slipped and investors responded to fresh…
Gold Price
Gold Price Today: Bullion Jumps Over 2%, but March Still Heads for Worst Month Since 2008
Gold jumped over 2% Tuesday, with spot prices hitting $4,608.16 per ounce and U.S. futures at $4,639.00. Still, that rebound couldn’t reverse what’s now…
Stock Market
Dow Jones Today: Index Rebounds on Iran De-escalation Hopes, but Worst Month Since 2022 Still Looms
The Dow Jones Industrial Average climbed roughly 1.2%, closing at 45,764.14 on Tuesday, as traders speculated that Washington could pull back from its military…
NasdaqNASDAQ:AVGO
US Stock Market Today: Wall Street Rallies, Nasdaq Jumps, but S&P 500 Still Faces Worst Quarter Since 2022
U.S. stocks pushed higher Tuesday after the Wall Street Journal said President Donald Trump was open to ending the military operation in Iran even…
Electric VehiclesGreen Technology
NIO Opens First Americas Store in Costa Rica as Chinese EV Maker Pushes Overseas Growth
NIO Inc just launched its first NIO House in Costa Rica, planting a retail flag in Latin America and stepping into the Americas for…
NYSE:SNAPStock Market
Snap Stock Jumps as Activist Irenic Targets Specs, Costs and Governance
Snap shares surged Tuesday, rallying roughly 12% to $4.50 in midday action, after Irenic Capital Management revealed it holds an economic stake equivalent to…
NASDAQ:MRVLNASDAQ:NVDA
Dow, S&P 500, Nasdaq Rebound as Trump Signals Flexibility on Strait of Hormuz, but Oil Risk Lingers
U.S. stocks bounced back Tuesday morning, after the Wall Street Journal said President Donald Trump had indicated to aides he’d end the military operation…
ETFsNasdaq
TQQQ, QLD Bets Grow at Wealth Advisers as Nasdaq Correction Tests Leveraged ETFs
Several U.S. wealth managers bulked up on leveraged Nasdaq-100 bets at year-end, filings show. Sherman Wealth Management snapped up 42,668 shares of ProShares UltraPro…
NYSE:PFEPharmaceuticals
Is Pfizer Stock a Buy? Shares Hit Fresh High as Bulls and Bears Clash Over Valuation
Pfizer hit a new 52-week high Tuesday, lifted by upbeat analyst notes and a string of pipeline news fueling demand. Shares last changed hands…
NASDAQ:APLSNASDAQ:BIIB
Apellis Pharmaceuticals Jumps as Biogen Agrees $5.6 Billion Buyout
Biogen said Tuesday it’s acquiring Apellis Pharmaceuticals in a cash deal valued near $5.6 billion, offering Apellis shareholders $41 per share upfront and additional…